Molly® is a single-dose autoinjector technology developed to help pharma and biotech companies reduce initial investments and expedite development timelines.
Molly’s modular autoinjector platform technology takes a unique approach to platform design by integrating modules into its ecosystem. These modules refer to the Molly device design and core technology, manufacturing infrastructures, and add-on features that respond to digital health and sustainability imperatives, as well as the ever-changing market landscape.
The Molly autoinjector is designed with an ergonomic body and a flange-shaped anti-roll cap for an easier handling experience.
Key features
- Simple two-step operation
- Needle cover activation
- Audible, visual and tactile feedback
- One-handed operation
- Ultra-compact design
- Permanently hidden needle
- Passive locking needle cover
- Pre-configured or customised to client specifications